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Abstract
Background: DNA polymerases α and δ play essential roles in the replication of chromosomal
DNA in eukaryotic cells. DNA polymerase α (Pol α)-primase is required to prime synthesis of the
leading strand and each Okazaki fragment on the lagging strand, whereas DNA polymerase δ (Pol
δ) is required for the elongation stages of replication, a function it appears capable of performing
on both leading and lagging strands, at least in the absence of DNA polymerase ε (Pol ε).
Results: Here it is shown that the catalytic subunit of Pol α, Pol1, interacts with Cdc27, one of
three non-catalytic subunits of fission yeast Pol δ, both in vivo and in vitro. Pol1 interacts with the
C-terminal domain of Cdc27, at a site distinct from the previously identified binding sites for Cdc1
and PCNA. Comparative protein sequence analysis identifies a protein sequence motif, called the
DNA polymerase interaction motif (DPIM), in Cdc27 orthologues from a wide variety of
eukaryotic species, including mammals. Mutational analysis shows that the DPIM in fission yeast
Cdc27 is not required for effective DNA replication, repair or checkpoint function.
Conclusions: The absence of any detectable phenotypic consequences arising from mutation of
the DPIM suggests that despite its evolutionary conservation, the interaction between the two
polymerases mediated by this motif is a non-essential one.
Background
Three conserved DNA polymerase enzymes whose activi-
ties are essential for complete chromosomal DNA replica-
tion have been identified through biochemical studies in
mammalian systems [1] and combined genetic and bio-
chemical studies in yeast [2]. During S-phase, the DNA
polymerase  α-primase complex synthesises the short
RNA-DNA segment that is used to prime synthesis of the
leading strand at the chromosomal replication origin and
synthesis of each Okazaki fragment on the lagging strand.
The short RNA segment is synthesised by the primase and
then extended by 10–20 nucleotides by Pol α. The 3' end
of the RNA-DNA primer is recognised by replication factor
C (RFC), which displaces the Pol α-primase complex and
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catalyses the loading of the sliding clamp PCNA at the
primer-template junction. PCNA then acts as a processiv-
ity factor for the Pol δ and/or Pol ε enzymes. The exact
roles played by Pol δ and Pol ε remain unclear (for a
recent perspective, see ref. [3] and references therein) but
Pol δ is most likely responsible for lagging strand replica-
tion and may also play a role on the leading strand. Yeast
lacking Pol ε catalytic activity are viable but are slow grow-
ing and somewhat impaired in chromosome replication
[4-7]. In such cells, Pol δ is thought to perform the bulk of
nascent DNA chain elongation, raising the possibility that
this enzyme performs a similar function in wild-type cells.
If this is the case, Pol ε could have a specialised role, at
replication origins for example, or in the replication of
sites of sister chromosome cohesion [3].
Each of the three essential polymerases is a multi-subunit
entity, comprising a large catalytic subunit and a number
of smaller subunits that are presumed to play either regu-
latory or structural roles [2]. Little is known of the bio-
chemical functions of the smaller subunits but in yeast
most are, like the three catalytic subunits, essential pro-
teins. In the fission yeast Schizosaccharomyces pombe, the
Pol α-primase and Pol δ complexes are both heterotetra-
meric in structure [2]. The catalytic subunits of the two
complexes, Pol1 and Pol3 respectively, are members of
the B family of DNA polymerases typified by bacteri-
ophage T4 polymerase or Pfu [8]. Both complexes also
contain related B-subunits. These proteins are members of
a larger family of phosphotransferase and nuclease
enzymes [9,10], although no enzymatic activity has been
detected for either of the DNA polymerase subunits. In fis-
sion yeast, the B-subunit of Pol δ is the Cdc1 protein. Fis-
sion yeast Pol δ also contains two further subunits: the C-
subunit Cdc27, which functions in part to link the
polymerase to PCNA [11,12], and the D-subunit Cdm1.
Of the four Pol δ subunits, only Cdm1 is non-essential
[13]. Orthologues of all four of these proteins (Pol3,
Cdc1, Cdc27 and Cdm1) make up mammalian Pol δ
[14,15].
Perhaps surprisingly, there have been few reports of phys-
ical interactions between the various polymerase enzymes
believed to be present at the eukaryotic replication fork.
One exception to this comes from large-scale functional
analysis of the budding yeast proteome where an interac-
tion was uncovered between the catalytic subunit of the
Pol α-primase complex, Pol1, and the C-subunit of the
Pol δ complex in budding yeast, Pol32 [16]. Interaction
between these proteins was detected using the two-hybrid
system, raising the possibility that the interaction was not
a direct one, but was instead mediated via a third protein
factor or complex. Recently, the two-hybrid result was
independently confirmed and a direct interaction
between the budding yeast Pol α-primase and Pol δ dem-
onstrated by mixing of the purified enzyme complexes
followed by co-immunoprecipitation [17]. By this
method, Pol α-primase and Pol δ were shown interact in
a Pol32-dependent manner [17]. A form of Pol δ contain-
ing a mutant Pol32 protein lacking a 40 amino acid region
of the C-terminal domain (Pol32-8, lacking amino acids
270–309) was also shown to be unable to co-immunopre-
cipitate with Pol α-primase [17], providing the first indi-
cation of the location of the Pol α binding site on Pol32.
In this paper, it is shown that the orthologues of the bud-
ding yeast Pol1 and Pol32 proteins in fission yeast, Pol1
and Cdc27 respectively, also interact in the two-hybrid
system. It is also shown that these proteins are capable of
interacting directly with one another, in vitro, using puri-
fied recombinant proteins and peptides. Interaction is
also seen between the human Cdc27 and Pol1 homo-
logues, p66 and p180. The binding site for Pol1 maps to
the extended C-terminal domain of the Cdc27 protein
and requires the presence of a short protein sequence
motif, which we have designated the DPIM, for DNA
polymerase interaction motif. This short sequence is con-
served in Cdc27 orthologues from a wide variety of
eukaryotic species. Despite this evolutionary conserva-
tion, mutational inactivation of the Pol1 binding motif
does not affect Cdc27 function in vivo. The implications of
these results are discussed.
Results
Interaction between fission yeast Pol1 and Cdc27
To test for interaction between fission yeast Pol1 and
Cdc27, the two-hybrid system was used. Full-length
Cdc27 fused to the activation domain (AD) of the yeast
Gal4 protein was tested for its ability to interact with
amino acids 278–527 of fission yeast Pol1 fused to the
DNA binding domain of the bacterial transcription factor
LexA (see Materials and methods for details). Amino acids
278–527 correspond to the smallest region of budding
yeast Pol1 shown to interact with Pol32 [16]. Reporter
gene induction, measured by β-galactosidase activity
assay, was observed in the presence of the Gal4 AD-Cdc27
and LexA-Pol1-278-527 (LexA-Pol1) proteins, but not
when either protein alone was present (Figure 1 and Table
1A, upper part). Thus, as in budding yeast, the catalytic
subunit of Pol α is able to interact with the C-subunit of
Pol δ.
Mapping the Pol1 binding site on Cdc27
Previously, minimal Cdc1 and PCNA binding regions on
Cdc27 have been mapped [11,12,18]. Cdc1 binds within
the globular 160 amino acid N-terminal domain of the
372 amino acid Cdc27 protein, whereas PCNA binds at
the extreme C-terminus of Cdc27 at a conserved p21Cip1-
like PCNA binding sequence, the PIP box. To map the
Pol1 binding site, a series of thirteen truncated Cdc27BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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proteins fused to the Gal4 AD were tested against LexA-
Pol1 in the two-hybrid system. The results of this analysis
are shown in Figure 1. Pol1 binds within the extended C-
terminal domain of Cdc27, with the smallest construct
capable of binding spanning a forty amino acid region,
from amino acids 293–332. Therefore, the Pol1 binding
region is distinct from both the globular N-terminal
domain and C-terminal PIP box. In support of this, two-
hybrid analysis showed that Cdc27 could bind to both
Pol1 and Pcn1 (PCNA) proteins simultaneously: Gal4
Mapping of the Pol1 interaction site on Cdc27 using the two-hybrid system Figure 1
Mapping of the Pol1 interaction site on Cdc27 using the two-hybrid system. Full-length and thirteen truncated 
Cdc27 proteins, expressed as Gal4 transcription activation domain fusions, were tested for their ability to interact with Cdc1-
LexA, Pcn1-LexA and Pol1(278–512)-LexA baits in S. cerevisiae CTY10-5d. Interactions were monitored by β-galactosidase 
activity, as described in Material and methods, and are indicated as +++ (strong interaction, typically 80–100 Miller units of β-
galactosidase activity), + (weak interaction, <20 Miller units), – (no interaction detectable above background, <1 Miller unit). 
The area between the broken vertical lines indicates the minimal Pol1 binding region, corresponding to amino acids 293–332 of 
Cdc27. The grey box indicates the minimal Cdc1 binding domain, amino acids 1–160; the black box represents the Pcn1 
(PCNA) binding motif (amino acids 362–372).BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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AD-Pcn1 and LexA-Pol1 fusion proteins (which do not
interact in the two-hybrid system) could be brought
together by co-expression of Cdc27 (Table 1A, lower part).
Cdc27-Pol1 interactions with recombinant proteins
In order to test whether the interaction between Pol1 and
Cdc27 was a direct one, purified recombinant Cdc27 and
Pol1 proteins were assayed for their ability to interact in
vitro. Purified GST-Cdc27-273-352 fusion protein [11]
was tested for its ability to pull-down purified recom-
binant hexahistidine-tagged Pol1 (amino acids 278–527).
The results (Figure 2) mirror those seen with the two-
hybrid assays and provide the first evidence that the inter-
action between the Cdc27 and Pol1 proteins is a direct
one, rather than being mediated via a third protein or set
of proteins, such as one of the other subunits of the Pol α-
primase or Pol δ complexes.
Pol1 binding site sequence
Previously, Cdc27 homologues from fission yeast [11,18],
budding yeast [19,20], human, mouse [21], and Xenopus
[15] have been identified and characterised. To extend
this family, BLAST [22] and ψ-BLAST searches [23,24]
were performed to identify putative Cdc27 family mem-
bers from other eukaryotic species. In all, 24 protein
sequences were identified, from organisms as diverse as
vertebrates, worms, fungi and plants. Protein sequence
alignments (Figure 3) of the C-terminal regions of these
proteins identified a set of highly conserved amino acids
that form a putative DNA polymerase interaction motif
(or DPIM) with the consensus sequence D(D/E)-G -- (V/
I)(T/S). The sequences flanking the DPIM are generally
highly charged in character and some sequence conserva-
tion (particularly of charged amino acids) is apparent in
these regions. Mutagenesis and peptide binding studies
(described below) suggest that, in addition to the DPIM,
some of these sequences may also play a role in binding
Pol1 (see Discussion).
Interaction between human Pol1 and Cdc27 orthologues
To examine whether the Pol1-Cdc27 (Pol1-Pol32) inter-
action observed in the yeasts was also conserved in higher
eukaryotes, the catalytic subunit of human Pol α and the
human Cdc27 orthologue p66/KIA00039 were assayed
Table 1: Two-hybrid analysis. Prey and bait proteins were expressed as Gal4 AD and LexA BD fusions from pACT2 and pBTM116 
respectively. Positive interactions corresponded to 50–100 Miller units (++) or 10–20 Miller units (+) of β-galactosidase activity. 
Negative interactions corresponded to < 2 units. See text for details.
Prey Bait Bridge Interaction
A. Fission yeast proteins
C d c 2 7 ---
- Pol1(278–527) - -
Cdc27 Pol1(278–527) - ++
Pcn1 Pol1(278–527) - -
Pcn1 - Cdc27 -
- Pol1(278–527) Cdc27 -
Pcn1 Pol1(278–527) Cdc27 +
B. Human proteins
-P o l   α (291–540) - -
p66 (253–466) - - -
p66 (356–466) - - -
p66 (253–466) Pol α (291–540) - ++
p66 (356–466) Pol α (291–540) - ++
C. Cross-species interactions
- Pol1(278–527) - -
p66 (253–466) Pol1(278–527) - ++
p66 (356–466) Pol1(278–527) - ++
Cdc27 Pol α (291–540) - -
D. Truncated Pol1 proteins
Cdc27 Pol1(278–527) - ++
Cdc27 Pol1(328–527) - -
Cdc27 Pol1(278–477) - -
Cdc27 Pol1(278–487) - -
Cdc27 Pol1(278–497) - -
Cdc27 Pol1(278–507) - -
Cdc27 Pol1(328–477) - -
Cdc27 Pol1-TS13(278–527) - -BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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Direct interaction between recombinant Pol1 (278–512) and Cdc27 proteins Figure 2
Direct interaction between recombinant Pol1 (278–512) and Cdc27 proteins. A. Expression of H6-Pol1 (278–512) 
in E. coli detected by immunoblotting using anti-MRGS antibodies. Total protein extracts prepared from cells carrying the con-
trol plasmid pQE32-Pol1 (278–512)-REV (lanes 1, 2), in which the relevant pol1+ sequence is present in the wrong orientation, 
or pQE32-Pol1 (278–512) (lanes 3, 4), either before (lanes 1, 3) or after (lanes 2, 4) induction of protein expression by addition 
of IPTG. The position of the 25 kDa marker is shown. B. Purified GST and GST – Cdc27 (273–352) proteins detected by 
Coomassie staining following SDS-PAGE. C. Binding assays using GST – Cdc27 fusion proteins. Bound H6-Pol1 was detected 
by Western blotting as in part A. Lanes 1, 3, 5: binding of H6-Pol1 to GST. Lanes 2, 4, 6: binding of binding of H6-Pol1 to GST 
– Cdc27 (273–352). In each case the bound fraction corresponds to approximately 15–20% of the input. Lanes 1 and 2: assay 
performed in PBS containing 0.1% Triton X100; lanes 3 and 4: PBS containing 0.25% Triton X100; lanes 5 and 6: PBS containing 
0.5% Triton X100. In the absence of detergent Pol1 binds equally well to both GST and GST-Cdc27 (273–352) proteins.BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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Sequence alignment of Pol1 interacting region from fission yeast Cdc27 and homologues in other eukaryotic species Figure 3
Sequence alignment of Pol1 interacting region from fission yeast Cdc27 and homologues in other eukaryotic 
species. Conserved residues are boxed. Abbreviations and NCBI sequence accession numbers: Sp (S. pombe, P30261), Sc (S. 
cerevisiae, P47110), Nc (Neurospora crassa, XP_328704), Ca (Candida albicans, EAK99562), Gz (Gibberella zeae, XP_384433), 
Um (Ustilago maydis, XP_401381), Cn (Cryptococcus neoformans, EAL21672), Dh (Debaryomyces hansenii, CAG87841), Dm (Dro-
sophila melanogaster, AAD38629), Ss (Sus scrofa, BF078337), Mm (Mus musculus, Q9EQ28), Rn (Rattus norvegicus, XP_215011), 
Cf (Canis familiaris, CF411342), Hs (Homo sapiens, Q15054), Ci (Ciona intestinalis, AK114729), Fr (Fugu rubripes, protein 
sequence derived by translation of clone M001240 at http://fugu.hgmp.mrc.ac.uk/), Tn (Tetraodon nigroviridis, CAF97746), Dr 
(Danio rerio, AAH76031), Xl (Xenopus laevis, BAC82197), Att (Ambystoma tigrinum tigrinum, CN059104), Gg (Gallus gallus, 
BU121824 – note the additional glutamate residue within the DPIM), Ce (C. elegans, Q21730), Os (Oryza sativa, NP_913217), 
and At (Arabadopsis thaliana, C96815). Note that in only a few cases (Sp, Sc, Hs, Mm, Xl) have the identities of these putative 
Cdc27 proteins been confirmed via purification and characterisation of Pol δ. However, all the sequences shown possess a 
canonical PCNA binding motif at or near their C-terminal ends (Q -- I -- FF), in common with the bone fide Cdc27 proteins.BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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for interaction using the two-hybrid system. Amino acids
291–540 of the human Pol α catalytic subunit, corre-
sponding to the minimum Cdc27 binding region (amino
acids 278–527) in fission yeast Pol1, were expressed as a
LexA fusion alongside Gal4 activation domain fusions of
either the entire C-terminal domain of human p66
(amino acids 253–466) or the C-terminal 111 amino
acids only (356–466). Interactions were tested by β-galac-
tosidase assay. Both p66 constructs bound to Pol α (Table
1B), indicating that the DNA polymerase interaction is a
conserved feature. In addition, it was observed that
human p66 was able to interact with fission yeast Pol1
(Table 1C), suggesting that conserved sequences (or struc-
tural features) within the Cdc27/p66 C-terminal region,
such as the DPIM, were important for the interaction.
Mutational analysis of Pol1 binding site on Cdc27
Next, the importance for Pol1 binding of the conserved
amino acids in the DPIM was examined. Eight mutant
Cdc27 proteins (Cdc27-P1 through Cdc27-P7, and
Cdc27-Q1, see Figure 4) were expressed as Gal4-Cdc27-
273-352 fusion proteins and tested for their ability to
bind to LexA-Pol1 (278–527) in the two-hybrid system.
In each mutant protein one or more conserved amino
acids is replaced with alanine. For example, the Cdc27-P1
mutant sees the conserved triplet DEE (residues 309–311)
substituted with AAA. The results of this analysis are
shown in Figure 4. Mutating the conserved amino acids of
the DPIM (mutants Cdc27-P1, P2 and Q1) completely
abolished Pol1 binding in vivo by Cdc27. Similar reduc-
tions were seen with the Cdc27-P4 and Cdc27-P6
mutants, where the mutated residues are located N-termi-
nal and C-terminal to the DPIM respectively. The con-
served amino acids of the DPIM are therefore essential for
Pol1 binding by Cdc27, although sequences flanking the
conserved motif also play a role. Only three of the eight
mutant proteins (Cdc27-P3, P5 and P7) were able to
interact with LexA-Pol1 (278–527), though the strength
of the interaction was reduced to 30–40% of the wild-type
value for Cdc27-P3 and Cdc27-P5 (both of which affect
residues N-terminal to the conserved motif), and to ~
10% of wild-type for Cdc27-P7 (located C-terminal to the
conserved motif). Immunoblotting showed that all the
mutant proteins were present in yeast protein extracts at
the same level as the wild-type Gal4-Cdc27 fusion protein
(data not shown).
The observation that sequences flanking the DPIM play a
role in Pol1 binding was supported by the results of stud-
ies performed with a nested set of overlapping 20 mer
peptides derived from the S. pombe Cdc27 sequence (see
Figure 5A). The peptides were tested for their ability to
bind to an epitope-tagged form of the Pol1 protein (Pol1-
13Myc, see Materials and methods) in fission yeast pro-
tein extracts. As can be seen in Figure 5B, Pol1-13myc is
precipitated by peptides SpB, SpC and SpD, but not SpA
and SpE. Peptide SpC spans the groups of basic amino
acids N-terminal to the conserved motif, including those
shown to be required for Pol1 binding as defined by the
Cdc27-P3 and -P5 mutants above, but does not include
the conserved sequence DEEGFLVT indicating that, in this
in vitro situation, the conserved amino acids are not abso-
lutely required for Pol1 binding, in contrast to what is
observed in vivo. Similar results were observed with pep-
tides derived for the human p66 protein sequence (Figure
5C,5D), again illustrating the potential for cross-species
interaction between human p66 and fission yeast Pol1
(see Table 1C).
Mapping the Cdc27 binding site on Pol1
In an effort to map more precisely where within the Pol1
protein Cdc27 binds, several truncated forms of Pol1
(278–527) were constructed and tested as LexA fusions in
the two-hybrid system (see Materials and methods for
details). Removal of fifty amino acids from the N-termi-
nus, or twenty amino acids from the C-terminus, of the
Pol1 (278–527) protein was found to abolish the interac-
tion with Cdc27 altogether (Table 1D).
Previously, the isolation of a temperature-sensitive
mutant  pol1  allele,  pol1-ts13, had been reported [25].
Sequence analysis revealed that this allele differed from
the wild-type pol1+ by deletion of 9 bp from the ORF,
resulting in loss of three amino acids (L470, S471, R472)
from within the minimal Cdc27 binding domain defined
above. In this study, the ability of a Pol1-TS13(278–527)
bait to bind to Cdc27 was tested using the two-hybrid sys-
tem. No interaction could be detected at a range of growth
temperatures (Table 1D, and data not shown), indicating
that amino acids 470–472 are required for Cdc27 binding
by Pol1(278–527). To test whether overproduction of
Cdc27 might rescue the temperature-sensitive phenotype
of pol1-ts13, these cells were transformed with plasmid
pREP3X-Cdc27 [18] and transformants plated at restric-
tive and semi-restrictive temperatures on thiamine-free
medium, to induce high-level expression of cdc27+ from
the thiamine-repressible nmt promoter. No suppression
of the pol1-ts13 phenotype was observed, however (data
not shown). Indeed, no suppression was observed of any
of three pol1 alleles that were analysed in this way, the oth-
ers being pol1-1 [26] and pol1-H4 [27].
Expression of DPIM mutants in vivo
To assay the in vivo role of the DPIM in Cdc27, four of the
eight DPIM mutant alleles (cdc27-P1 through cdc27-P4)
were cloned into plasmid pREP3X, 3' to the repressible
nmt1 promoter [28,29], and transformed into a cdc27+/
cdc27::his7+ diploid strain. Transformant colonies were
then induced to sporulate and the spores plated on media
containing thiamine, to repress the nmt1 promoter.BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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Under these conditions, residual low level expression
from the nmt1 promoter ensures that the level of Cdc27
protein present in the cell is comparable to that seen in
wild-type cells [12]. Analysis of the meiotic products
showed that the mutant Cdc27 proteins were able to sup-
port growth of cdc27∆ haploid cells; indeed, no pheno-
typic defects were apparent (data not shown).
To confirm this, a fission yeast strain was constructed in
which the endogenous cdc27+ gene was precisely replaced
with the cdc27-Q1 mutant allele. In the Cdc27-Q1 mutant
protein, the central five amino acids of the DPIM are
replaced with alanine, resulting in loss of Cdc27-Pol1
interaction in the two-hybrid system (Figure 4). Construc-
tion of the cdc27-Q1 strain was achieved by first replacing
one copy of cdc27+ with ura4+ in a diploid strain, before
then replacing the cdc27::ura4+ allele with cdc27-Q1 via 5-
FOA counterselection in the cdc27::ura4+ haploid carrying
cdc27-Q1 on a plasmid (see Materials and methods for
details). PCR analysis of genomic DNA using primers spe-
cific for wild-type cdc27+ and cdc27-Q1 sequences (see Fig-
ure 6 and legend) allowed the identification of haploid
strains in which cdc27-Q1 was correctly integrated at the
Mutational analysis of Pol1 binding domain on Cdc27 Figure 4
Mutational analysis of Pol1 binding domain on Cdc27. A. Summary schematic of minimal Pol1 binding region on Cdc27, 
showing conserved amino acids (boxed) and the eight mutant alleles P1 through P7 and Q1. Each mutant sees two or three 
adjacent residues being replaced with the same number of alanines. In the case of P1 and P3 through P7, adjacent basic (P3, P4 
and P5) or acidic (P1, P6 and P7) amino acids are mutated. B. Quantitation of β-galactosidase activity in liquid cultures. Key: C 
(pACT2 vector); W (pACT-Cdc27-273-352), mutants P1 – P7, plus Q1 (mutated forms of pACT-Cdc27-273-352); F (pACT-
Cdc27, i.e. full-length Cdc27 fused to Gal4).BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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Peptide binding studies Figure 5
Peptide binding studies. A. Schematic of the structure of the Cdc27 protein (upper part) with the sequences of overlapping 
peptides SpA-SpE shown beneath. B. Immunoblot using anti-myc mAb showing pull-down of Pol1-13Myc protein from fission 
yeast protein extracts by Sp series peptides. C. Sequences of human peptide set HsA-HsE corresponding exactly to SpA-SpE 
above. D. Immunoblot using anti-myc mAb showing pull-down of Pol1-13Myc protein from fission yeast protein extracts by Hs 
series peptides.BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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endogenous cdc27+ locus, and also allowed the cdc27-Q1
mutant to be conveniently followed through genetic
crosses.
Phenotypic analysis of cdc27-Q1 cells, in comparison to
an otherwise isogenic cdc27+ control, revealed the follow-
ing: cells carrying the cdc27-Q1 allele grew normally at a
range of temperatures (18 – 36.5°C), with a generation
time indistinguishable from wild-type (110 minutes at
32°C in YE medium). At 32°C, cdc27-Q1 cells underwent
division at ~ 14.1 µm (compared to wild-type at ~ 14.4
µm). Further analysis showed that the cdc27-Q1 cells were
indistinguishable from wild-type in all respects examined,
including responses to the DNA replication inhibitor
hydroxyurea (HU) and the DNA damaging agents
methylmethane sulphonate (MMS), camptothecin (CPT),
bleomycin sulphate (BMS) and UV light (see Materials
and methods for details). The kinetics of cell division
arrest in response to HU were also examined, but again no
difference was detectable between cdc27-Q1 and wild-type
strains (data not shown). That cell number increase is
arrested in cdc27-Q1  cultures following treatment with
HU, and that both wild-type and cdc27-Q1 cells become
highly elongated under these conditions, is indicative of
the presence of a functional DNA replication checkpoint
in these cells. Taken together, these results strongly sug-
gest that the Pol1-Cdc27 interaction does not play an
essential role either during S-phase or in various DNA
repair pathways in fission yeast.
The consequences of introducing additional mutations
into the cdc27-Q1  background were also investigated.
cdc27-Q1 was crossed to strains carrying mutations in the
other three subunits of Pol δ (pol3-ts3, cdc1-P13, cdm1∆)
and in the helicase-endonuclease Dna2 and its associated
protein Cdc24 (dna2-C2 and cdc24-M38). [13,18,30-33].
The double mutant strains were then analysed as
described in Materials and methods. In every case exam-
ined, the properties of the double mutant with cdc27-Q1
were indistinguishable from the single mutant. The cdc27-
Q1  mutation was also combined with rad3∆  [34] and
cds1∆ [27] alleles, to create cdc27-Q1 rad3∆ and cdc27-Q1
cds1∆ double mutants, both of which were viable. The
Rad3 and Cds1 proteins are key components of various
DNA structure checkpoints in fission yeast [35]. That the
cdc27-Q1  double mutants were viable indicates that
cdc27-Q1 cells do not require the presence of a functional
checkpoint for viability. When wild-type cells are treated
with hydroxyurea, activation of Cds1 results in cell cycle
arrest and replication fork stabilisation. In the absence of
Cds1, however, replication forks are believed to collapse,
resulting in loss of viability [35]. The rad3∆ and cds1∆
double mutants were tested for their sensitivity to HU and
CPT, but as before, no differences were observed between
Construction and analysis of cdc27-Q1 mutant yeast Figure 6
Construction and analysis of cdc27-Q1 mutant yeast. 
A. Upper part: Schematic of the cdc27+ gene region (3.1 kb 
HindIII-BamHI region) showing location of oligonucleotides 
used for PCR amplification. (Key to oligonucleotides: Aw = 
CDC27-Q1W-DIAG2, Am = CDC27-Q1M-DIAG2, B = 
CDC27-B, C = CDC27-SEQ2005, D = CDC27-H, X = 
CDC1-AB, and Y = CDC1-XY – see Material and methods 
for sequences). The boxes indicate approximate positions of 
cdc27+ exons. The NotI site shown is found in the cdc27-Q1 
allele only. Lower part: Genomic DNA prepared from wild-
type (WT) and cdc27-Q1 (Q1) strains was amplified using the 
primer pairs shown. The D+B PCR product from cdc27-Q1 
alone can be digested with NotI (data not shown). The 
primer pair X and Y amplify an unrelated region of genome, 
and were included as a control. Molecular weight markers 
(kb) are shown to the right of the gel. B. Wild-type (cdc27+, 
left) and cdc27-Q1 (right) cells plated on YE medium and 
incubated for 3 days at 32°C. Mutation of the DPIM did not 
affect the efficiency of colony formation or growth rate. See 
text for details.BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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single and double mutants with cdc27-Q1  (data not
shown).
Discussion
In fission yeast, DNA polymerase δ is a multisubunit com-
plex comprising a large catalytic subunit that is required
for chromosomal replication as well as three smaller sub-
units, two of which are also essential for cell viability
[13,18,36]. Understanding how the four subunits of the
complex interact with one another, and how they interact
with other components of the replication machinery, is an
important goal. Once interactions are identified and the
sites of interaction precisely mapped, reverse genetic anal-
ysis allows determination of the effects of disrupting indi-
vidual protein-protein interactions on replisome
function.
In this paper we show that the C-subunit of fission yeast
Pol δ, Cdc27, is able to interact both in vivo and in vitro
with Pol1, the catalytic subunit of Pol α. The Pol1 binding
site on Cdc27 has been mapped by in vivo and in vitro
approaches and a region of 40 amino acids, from amino
acids 293 – 332, has been shown to be sufficient for bind-
ing. Protein sequence alignments of Cdc27 homologues
across this 40 amino acid region identify a short protein
sequence motif (D -- G --VT) that is highly conserved and
which is essential for Pol1 binding. This DNA polymerase
interaction motif (DPIM) is flanked by relatively highly
charged sequences. Ten basic amino acids are found flank-
ing the DPIM in the fission yeast Cdc27 protein sequence,
nine of which are located N-terminal to the central
conserved motif. Similarly, there are ten acidic amino
acids, all of which lie either within the conserved DPIM or
C-terminal to it. Our mutagenesis data clearly implicates
several of these charged groups in the binding to Pol1
(Figure 4B). Secondary structure predictions suggest that
the conserved DPIM is likely to form a turn or loop,
raising the possibility that the sequences on either side of
the conserved motif interact with one another. The distri-
bution of positively and negatively charged amino acids
in most, though not all, of the Cdc27 homologues in
other species (Figure 3) is similar to that in fission yeast.
The most obvious exception to this is in the C. albicans
Cdc27 protein, where six acidic amino acids are found N-
terminal, and seven basic amino acids C-terminal, to the
DPIM. This organisation of charged residues appears
again to be compatible with the notion the sequences on
either side of the DPIM may interact with one another.
The Cdc27 protein has an elongated shape, with a fric-
tional ratio of 1.85 [12]. The same is true of its budding
yeast orthologue Pol32 which has a frictional ratio of 2.22
[37]. The elongated shape of Cdc27 is due to the C-termi-
nal region of the protein. The N-terminal Cdc1 binding
domain, comprising amino acids 1–160 [11], behaves in
solution as a globular protein [12]. The protein-protein
interaction motif described in this study is the second to
be mapped to the extended C-terminal domain.
Previously we showed that Cdc27 interacts with PCNA via
a conserved sequence at the extreme C-terminus of the
protein [11]. Our results indicated that this interaction
was essential for cell viability. Consistent with this,
Cdc27-PCNA contact is vital for maximal polymerase
processivity in vitro. However, recently we obtained evi-
dence that the Cdc27-PCNA interaction is a non-essential
one (H. Tanaka, G. Ryu, Y.-S. Seo and S.M., submitted).
Recently, the results of a deletion analysis of Pol32, the
budding yeast orthologue of Cdc27, were reported [17],
including analysis of Pol32-Pol1 interaction. The results
of these studies showed that amino acids 270–309 of
Pol32 were required for Pol1 binding in the two-hybrid
system. This region corresponds to amino acids 286–325
in fission yeast Cdc27 and includes the conserved DPIM
sequence (Figure 3). Deletion of amino acids 250–289
(266–305 in Cdc27) greatly reduced Pol1 binding, con-
sistent with the results reported here with the Cdc27-P3, -
P4 and -P5 mutants (Figure 4), as did deleting amino
acids 310–343 (326–363), consistent with the Cdc27-P7
mutant result. (As expected, the latter Pol32 deletion also
disrupted binding to PCNA.) In addition, it was shown
that that Pol α-primase and Pol δ could be co-immuno-
precipitated following mixing of the purified complexes,
but that this interaction was effectively abolished when
Pol  δ contained the 270–309 deletion of Pol32 rather
than the full-length protein [17].
In this paper, cells expressing the DPIM mutant protein
Cdc27-Q1 were shown to be no more sensitive then wild-
type to HU, MMS, CPT, UV and BMS (see Results), while
analysis of budding yeast cells expressing Pol32 lacking
the DPIM (270–309 deletion) showed them to be no
more sensitive than wild-type to HU and UV, and to show
normal rates of mutagenesis following UV exposure [17].
Indeed, in all situations examined, S. pombe cdc27-Q1 cells
were indistinguishable from wild-type. No genetic inter-
actions were observed between cdc27-Q1  and various
other DNA replication or checkpoint mutants, including
the key checkpoint kinase Rad3.
In conclusion, while the interaction between Pol α-pri-
mase and Pol δ mediated via Cdc27 could play an impor-
tant role in coordinating the events of lagging strand
synthesis, we have yet to obtain any evidence that this is
the case. This raises two possibilities. First, that the
observed interaction does not play an important role in
chromosomal replication. We believe that this is unlikely
to be the case, given the high degree of conservation of the
DPIM sequence across evolution, in a region of the Cdc27
protein that is very poorly conserved at the primaryBMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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sequence level. The second possibility is that there are
multiple redundant interactions within the lagging strand
machinery. In this case, an important role for the Cdc27-
Pol1 interaction might only be uncovered when another
protein-protein interaction is perturbed, in which case,
the cdc27-Q1 mutation might be expected to be syntheti-
cally lethal or sick with a mutant that disrupted the over-
lapping redundant function. With the genetic tools
available in yeast, this is a hypothesis that is readily
testable.
Conclusions
In fission yeast, interaction between Pol α and Pol δ is
mediated, at least in part, by direct binding of the Pol δ C-
subunit Cdc27 to the Pol α catalytic subunit Pol1, and
requires the presence of a short sequence motif (DPIM) in
the C-terminal region of Cdc27. The DPIM is conserved in
all known Cdc27 orthologues. Despite this, it has not
been possible to identify any phenotypic consequences
associated with deletion of the DPIM sequence, raising
the possibility that the observed interaction does not play
a crucial role in vivo.
Methods
Yeast strains, media and methods
All fission yeast strains were as described previously,
except for pol1-H4  [27] and pol1-1  [26], which were
obtained from Dr J. Hayles (CR-UK, London, U.K.), and
pol1-ts13 [25], which was obtained from Dr T.S.F. Wang
(Stanford, U.S.A.). Note that this allele was originally des-
ignated polα-ts13 but is correctly renamed here to bring it
in line with accepted nomenclature standards (see http://
www.sanger.ac.uk/Projects/S_pombe/
SP_Name_FAQ.shtml for further details). S. pombe media
and techniques were essentially as described [38], with the
following exceptions. Routine transformation of S. pombe
was carried out by electroporation [39], whereas transfor-
mation for PCR-based gene targeting was accomplished
using a modified lithium acetate method [40]. For two-
hybrid analysis. S. cerevisiae CTY10-5d (MATa ade2 met-
trp1-901 leu2-3-112 his3-∆200 gal4-gal80-URA3::lexA-
LacZ) was used [18]. S. cerevisiae was cultured in YPDA
and SD medium.
Plasmids for two-hybrid assay
Two-hybrid interactions were monitored using the Gal4
transcription activation domain (prey) plasmid pACT2
(Clontech), the LexA DNA binding domain (bait) plas-
mid pBTM116, and S. cerevisiae lexA op-lacZ strain CTY10-
5d, as described previously [18].
The Pol1 bait plasmid pBTM116-Pol1-(278–527) was
constructed by amplifying sequences encoding amino
acids 278–527 from plasmid pTZ19R-Pol1 (prepared by
subcloning a 5925 bp SmaI-PstI fragment encompassing
the entire pol1+ gene from S. pombe cosmid SPAC3H5, see
http://www.sanger.ac.uk/Projects/S_pombe, into plasmid
pTZ19R) using oligonucleotides POL15 (5'-GTGTGGTTT-
GGGATCCCCCTATCACCAATGACACCTTTA-3') and
POL13-2 (5'-GTGTGGTTTGGGATCCTACATCACCGT-
CATTGGAGGCGT-3'), restricting the PCR product with
BamHI (sites underlined), cloning to pTZ19R (Fermen-
tas) and sequencing to confirm the absence of errors. The
763 bp BamHI fragment was then transferred to
pBTM116, to generate pBTM116-Pol1(278–527). Plas-
mid pBTM116-Pol1-TS13(278–527) was produced in a
similar manner, except that the starting PCR template was
genomic DNA prepared from pol1-ts13 cells [25], the final
product thereby containing a 9 bp deletion in the pol1+
ORF, resulting in the loss of coding capacity for amino
acids L470, S471 and R472. Plasmids expressing C-termi-
nally truncated Pol1(278–527) proteins were constructed
by PCR amplification using oligo POL15 in conjunction
with POL25-3 (5'-GTGTGGTTTGGGATCCTAAGGAC-
CCATAACTCTTCTACT-3'), POL13-487 (5'-GTGTGGTTT-
GGGATCCTAAAAATTTGGTTGTTGTATTTT-3'), POL1-
497 (5'-GTGTGGTTTGGGATCCTACCGGCACCAACTAG-
CATTTTT-3') or POL1-507 (5'-GTGTGGTTTGGGATC-
CTAGTTCTGAGGTGACGAACATCC-3'), cloning directly
to pBTM116 following BamHI cleavage of the PCR prod-
uct, and sequencing. The resulting constructs encoded the
following proteins as Lex A fusions: Pol1(278–477),
Pol1(278–487), Pol1(278–497) and Pol1(278–507). A
construct expressing an N-terminally truncated Pol1(278-
527) protein, designated Pol1(328–527), was generated
by amplification using POL15-2 (5'-GTGTGGTTT-
GGGATCCCCGGCTCATTGTGTCTATTTGGC-3') with
POL13-2 (above). Amplification with POL15-2 and
POL25-3 generated a construct with the potential to
express a LexA-Pol1 protein truncated at both ends: LexA-
Pol1(328–477).
Sequences encoding the C-terminal region from human
p66/KIAA0039 were amplified by PCR from plasmid
pET19b-p66 (a gift of Dr P. Hughes, Villejuif, France)
using either oligo P66-51 (5'-GTGTGGTTTGGGATC-
CCCTCAGAACAAGCAGTGAAAGAA-3') or P66-52 (5'-
GTGTGGTTTGGGATCCCGTCTCCACCTCTTGAAC-
CAGTG-3') with P66-3 (5'-GTGTGGTTTGGGATCCTT-
GGTCTTCACCCTTGACCACTC-3'). The PCR products
were then restricted with BamHI, cloned to pACT2 and
sequenced. The resulting plasmids encode, as Gal4 AD
fusions, either the entire C-terminal domain of p66/
KIAA0039 (amino acids 253–466, oligos P66-51 and P66-
3) or a shorter region (amino acids 356–466, oligos P66-
51 and P66-3). Sequences encoding the interacting
domain of the catalytic domain of human Pol α were
amplified from plasmid pBR322-Pol α (a gift of Dr T.
Wang, Stanford, USA) using oligos HPOL1-5 (5'-GTGT-
GGTTTGGGATCCCCAAAGGGACCGTGTCCTACTTA-3')BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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and HPOL1-3 (5'-GTGTGGTTTGGGATCCTACATCAC-
GACAAGCGGTGGTGG-3'), restricted with BamHI,
cloned to pBTM116 and sequenced. The resulting plasmid
encodes amino acids 291–540 of the human protein as a
LexA fusion.
The Cdc27 prey plasmids were constructed in pACT2
(Clontech) and have been previously described, with the
exception of mutants Cdc27-273-352-P1 through -P7,
and Cdc27-273-352-Q1. The first four of these (P1-P4)
were generated by PCR amplification from the pREP3X-
Cdc27-P1 to -Cdc27-P4 plasmids described below. Oligo-
nucleotides for PCR, with BamHI sites underlined:
PMUT5 (5'-GTTTGTTGGTGGATCCCCACCGAAG-
CAAAATCTGCTGCA-3') and PMUT3 (5'-GTTGTGGGT-
GGGATCCTACTTCTTAGTTGCAATGTTTAC-3'). Mutant
Q1 was generated by PCR amplification with same prim-
ers but using pHBLA-Cdc27-Q1 (below) as template. Plas-
mids expressing mutants P5-P7 were generated by overlap
extension PCR using PMUT5 and PMUT3 together with
the following mutagenic oligonucleotides (shown with
mutated sequence underlined in top strand oligo):
CDC27-P5F (5'-AAAGAAAAGTTGCAGCG-
TACGCGACAACGAAAG-3'), CDC27-P5R (5'-CTTTCGTT-
GTCGCGTACGCTGCAACTTTTCTTT-3'), CDC27-P6F (5'-
TTGGTTACTAAGGCAGCAGCAGTCTGGGAATCA-3'),
CDC27-P6R (5'-TGATTCCCAGACTGCTGCTGCCTTAG-
TAACCAA-3'), CDC27-P7F (5'-GAATCATTTTCT-
GCAGCTGCAAACATCTCAACT-3'), CDC27-P7R (5'-
AGTTGAGATGTTTGCAGCTGCAGAAAATGATTC-3').
Two-hybrid assays
Quantitative data for β-galactosidase activity was
obtained as described previously [18] and is expressed in
Miller units [41]. To analyse prey protein levels, yeast total
protein extracts, prepared from the same cultures used for
β-galactosidase assay, were subjected to SDS-PAGE and
immunoblotted using antibodies against the HA epitope
(12CA5, Roche Applied Science) present in proteins
expressed from pACT2.
Expression and purification of recombinant H6-Pol1 (278–
527)
The Pol1 (278–527) domain was expressed in E. coli with
an N-terminal MRGSH6-tag to facilitate purification and
detection. To achieve this, the 763 bp Pol1 (278–527)-
encoding BamHI fragment described above was cloned
into pQE32 (Qiagen). The resulting plasmid, pQE32-Pol1
(278–527), was transformed into E. coli M15 (pREP4)
and recombinant protein expression induced in 500 ml
cultures (OD600 nm of 0.6) by addition of IPTG to a final
concentration of 1 mM. Following incubation for 4 hours
at 37°C, the cells were pelleted and the pellet resuspended
in 40 ml of ice-cold buffer A (150 mM NaCl, 50 mM Tris-
HCl pH 8.0, 20 mM imidazole) containing EDTA-free
Complete™ inhibitors (Roche Applied Science) and 1 mM
PMSF. The cells were lysed by sonication, then centrifuged
at 25000 g for 15 minute at 4°C. The soluble supernatant
was added to 4 ml of 50% (v/v) Ni-NTA agarose (Qiagen)
in buffer A, mixed on a wheel at 4°C for one hour, then
packed into a disposable chromatography column at 4°C.
The column was drained of the flow-through and subse-
quently washed with 100 ml of buffer B (1 M NaCl, 50
mM Tris-HCl pH 8.0, 20 mM imidazole) containing Com-
plete™ inhibitors and PMSF, then 100 ml of buffer A con-
taining Complete™ inhibitors and PMSF, before the
bound H6-Pol1 protein was eluted using 4 ml of buffer C
(250 mM imidazole, 50 mM Tris-HCl pH 8.0). Following
elution, samples were analysed by SDS-PAGE and the
peak fractions pooled and dialysed overnight in PBS at
4°C. Protein concentration was determined by BCA assay
(Pierce) versus BSA standards.
Binding assays
GST and GST-Cdc27-273-352 fusion proteins were pre-
pared as described previously [11] from plasmid pGEX6P-
1B, a modified version of pGEX6P-1 (Amersham Pharma-
cia) in which the reading frame of the polylinker is altered
(S.M., unpublished). Sequences encoding wild-type and
mutant forms of Cdc27-273-352 were subcloned into this
vector from the equivalent pACT2 two-hybrid constructs
described above. Binding assays were performed by mix-
ing ~ 30 pmol of GST or GST-Cdc27-273-352 with 90
pmol of H6-Pol1 in PBS containing 1.0% Triton X100 for
1 hour at 4°C on a rotating wheel. The GST proteins were
then precipitated using Glutathione Sepharose™ 4 Fast
Flow resin (Amersham Biosciences) for 30 minutes at 4°C
on a rotating wheel. Following extensive washing with
PBS containing 0.1 – 1.0% Triton X100, SDS-PAGE sam-
ple buffer was added and the samples heated at 95°C for
5 minutes. Bound H6-Pol1 was visualised following elec-
trophoresis of 15% SDS-PAGE gels by PAGE Blue G90
(Fluka) staining or by immunoblotting with anti-MRGS
antibodies (Qiagen).
Construction of Pol1-13Myc strain
PCR-based gene targeting was used to tag the chromo-
somal pol1+ locus in an otherwise wild-type leu1-32 ura4-
D18 h- strain with sequences encoding thirteen copies of
the 9E10 (c-myc) mAb epitope, such that the encoded
Pol1 protein (termed Pol1-13Myc) carries the 9E10
epitopes at its C-terminus. Oligonucleotides for amplifi-
cation from pFA6a-13Myc-kanMX6 [40] were as follows:
POL1-13MYC-5 (5'-
TGCCATCAACAAAAATATCTCTCGAATAAT-
GAACAAAAATGCGCGTGAATTTGTAGATATGGGACT-
GATATTTTCATCGCGGATCCCCGGGTTAATTAA-3', with
plasmid-specific sequence underlined) and POL1-
13MYC-3 (5'-GGCAATTCCCAAGTCTTTGAAACAGGTAT-
TCCCATCAACATTTCTTGTACTGCATGAGCAAATATCT-BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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GTTCGAGGTGTCGAATTCGAGCTCGTTTAAAC-3').
Following transformation of ~ 10 µg of PCR product, cor-
rect G418-resistant integrants were identified by PCR
amplification of genomic DNA using primer FCGPOL1-5
(5'-ATGTCGTGGAAGCGTTCATT-3') within the pol1+ ORF
and KAN269R (5'-GATCGCAGTGGTGAGTAACCAT-
GCATCATC-3') within the kanMX6  cassette, and by
Western blotting using the mouse anti-Myc mAb 9E10
(Roche).
Peptide binding assays
Peptides were synthesized by Mimotopes (Australia). All
peptides were synthesized to contain the sequence biotin-
SGSG at the N-terminus. Peptide sequences: SpA AAP-
DEPQEIIKSVSGGKRRG; SpB PQEIIKSVSGGKRRG-
KRKVK; SpC KSVSGGKRRGKRKVKKYATT; SpD
GKRRGKRKVKKYATTKDEEG: SpE KRKVKKYATTKDEEG-
FLVTK; HsA PKTEPEPPSVKSSSGENKRK; HsB EPPSVKSSS-
GENKRKRKRVL; HsC KSSSGENKRKRKRVLKSKTY; HsD
ENKRKRKRVLKSKTYLDGEG; HsE RKRVLKSKTYLDGEG-
CIVTE. For binding assays, the peptides were initially
bound to 10 µl Streptavidin-agarose beads in PBS in a
final volume of 100 µl at room temperature for 1 hour
with gentle agitation. After binding, the beads were
washed 3 times with 100 µl PBS. Protein extracts (100 µg
of fission yeast extract) were added to the beads, and incu-
bated at 4°C for 1 hr with gentle agitation. The beads were
pelleted by centrifugation at 2000 rpm for 3 minutes, and
subsequently washed extensively with NP40 buffer (50
mM Tris-HCl pH 8.0, 150 mM NaCl, 1% (v/v) NP-40),
prior to final resuspension with 20 µl of SDS loading
buffer. Following SDS-PAGE, Pol1-13Myc was visualised
by immunoblotting with the mouse anti-Myc mAb 9E10
(Roche). Fission yeast protein extracts were prepared from
8 × 107 cells in mid-exponential growth in EMM medium.
Cells were harvested, washed once in STOP buffer (150
mM NaCl, 50 mM NaF, 10 mM EDTA, 1 mM NaN3) and
disrupted in buffer A (10 mM sodium phosphate buffer
pH 7.0, 1% Triton, 0.1% SDS, 1 mM EDTA, 150 mM
NaCl, 1 mM PMSF) supplemented with Complete™ pro-
tease inhibitors (Roche), using a bead beater (Hybaid
Ribolyser). Protein concentrations were determined at
595 nm using the BioRad protein assay reagent according
to the manufacturer's instructions, with BSA as standard.
Plasmids expressing DPIM mutants
Plasmids pREP3X-Cdc27-P1 to -Cdc27-P4 were con-
structed by cloning mutagenised cdc27+  cDNAs (SalI-
BamHI) from pTZ19R-Cdc27-cDNA [18] into pREP3X.
Mutagenesis of pTZ19R-Cdc27-cDNA was accomplished
using the MutaGene II mutagenesis kit (BioRad) accord-
ing to the manufacturer's instructions. Oligonucleotides
with mutated residues underlined: CDC27-P1 (5'-
AAAAGTACGCGACAACGAAAGCCGCAGCAGGATTCTT-
GGTTACTAAGG-3'), CDC27-P2 (5'-CGACAACGAAA-
GATGAAGAAGCCGCCTTGGTTACTAAGGAAGAAG-3'),
CDC27-P3 (5'-TCAAATCCGTATCCGGTGGAGCCGCAG-
CAGGGAAAAGAAAAGTTAAAAAG-3'), CDC27-P4 (5'-
CCGGTGGAAAGAGACGTGGGGCCGCAGCAGT-
TAAAAAGTACGCGACAAC-3'). The resulting mutant alle-
les were tested for function by transforming a cdc27+/
cdc27::his7+leu1-32/leu1-32 ura4-D18/ura4-D18 his7-366/
his7-366 ade6-M210/ade6-M216 h-/h+ diploid [11], trans-
ferring the transformants onto malt extract medium to
induce sporulation, before finally plating the helicase-
treated spores onto EMM plates supplemented with 5 µg/
ml thiamine with/without histidine, at 32°C.
Construction of DPIM mutant strain
A 3.1 kb HindIII-BamHI genomic DNA fragment carrying
the  cdc27+ gene was first cloned into pTZ19R to make
pHB-Cdc27. This vector was then modified by addition of
the S. cerevisiae LEU2 gene and S. pombe ars1, to make
pHBLA-Cdc27. The cdc27+ gene was then subjected to oli-
gonucleotide-directed  in vitro mutagenesis using the
QuikChange method (Stratagene) with oligonucleotides
CDC27-QC1 (5'-GTACGCGACAACGAAAGCTGCAgcg-
gccgcCTTGGTTACTAAGGAAGAAG-3', with mutated
sequence underlined and NotI site in lower case) and
CDC27-QC2 (5'-CTTCTTCCTTAGTAACCAAGgcggccgcT-
GCAGCTTTCGTTGTCGCGTAC-3'), to create plasmid
pHBLA-Cdc27-Q1. This was then was transformed into a
cdc27+/cdc27::ura4+  diploid, and cdc27::ura4+  (pHBLA-
Cdc27-Q1) haploids obtained following sporulation and
regrowth. These were then plated on YE plates containing
1 mg/ml 5-FOA. 5-FOA resistant colonies were identified,
purified and characterised by PCR amplification of
genomic DNA (prepared using the method of Bähler and
coworkers [40]), to ensure loss of the chromosomal ura4+
marker, its replacement with cdc27-Q1, and loss of the
pHBLA-Cdc27-Q1. Oligonucleotides for diagnostic PCR
shown in Figure 6: CDC27-Q1W-DIAG2 (5'-GCGACAAC-
GAAAGATGAAGAAGGATTC-3'; note that the underlined
region anneals only to the wild-type cdc27+ and not cdc27-
Q1); CDC27-Q1M-DIAG2 (5'-GCGACAACGAAAGCT-
GCAGgcggccgcC-3'; underlined region anneals only to
cdc27-Q1  and not to cdc27+; NotI site in lower case);
CDC27-H (5'-ACTGGTAGAATTGCGTTCGCGCTC-3');
CDC27-B (5'-TCTAGGATCAGAGTGAACTGATTG-3');
CDC27-SEQ2005 (5'-AGGTTGTACTAACATTAACAG-3').
The resulting strain, cdc27-Q1 leu1-32 ura4-D18 his7-366
ade6-M216 h- was then analysed alongside the wild-type
leu1-32 ura4-D18 his7-366 ade6-M216 h-, as described
below.
Phenotypic analysis
Cells were grown to mid-exponential phase (~ 5 × 106
cells/ml) in YE medium and ~ 2000 cells plated on YE
medium supplemented with varying concentrations of
hydroxyurea (2.5, 5, 7.5, 10, 12.5 mM),BMC Molecular Biology 2004, 5:21 http://www.biomedcentral.com/1471-2199/5/21
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methylmethanesulphonate (0.01, 0.005, 0.0025, 0.001,
0.0005, 0.00025, 0.0001%), bleomycin sulphate (2.5, 5,
7.5, 10, 12.5 mU/ml), or camptothecin (4, 4.5, 5, 5, 5.5,
6, 6.5, 7, 7.5, 8 µM). Cells were also plated on plates con-
taining sub-lethal doses of both HU and CPT, specifically
7.5 mM HU with either 5.5 or 6 µM CPT, or 10 mM HU
with either 5.5 or 6 µM CPT. To analyse the effects of HU
treatment in liquid culture, HU was added to EMM
medium to a final concentration of 12 mM. Cell number
per ml of culture was monitored using a Coulter Z1 elec-
tronic particle counterTo test sensitivity to UV, 1000 cells
were plated on EMM plates, allowed to dry for 20 min-
utes, then irradiated using either a Stratalinker UV source
(Stratagene) over the range 0 – 250 J/m2. Following UV
treatment, plates were placed immediately in the dark to
avoid photoreversal. For all treatments, the efficiency of
colony formation was determined after 4 days growth at
32°C. Growth rate (YE medium, 32°C) was determined
by cell counting using a particle counter. Cell length at cell
division was determined using a graduated eyepiece.
DPIM double mutants
Double mutants were constructed by standard methods,
with the cdc27-Q1 allele being identified by PCR analysis
of genomic DNA using CDC27-Q1W-DIAG2 and CDC27-
Q1M-DIAG2 oligonucleotides described above. Double
mutants were created with the following: pol3-ts3 [30],
cdc1-P13 [42], cdm1::ura4+[13], cdc24-M38 [43], dna2-C2
[31], rad3::ura4+ [34] and cds1::ura4+ [27].
List of abbreviations used
DPIM (DNA polymerase interaction motif); PCNA (pro-
liferating cell nuclear antigen).
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